Latest Breaking News On - Crinetics pharmaceuticals inc - Page 3 : comparemela.com

Crinetics Pharmaceuticals Appoints Robert M Cuddihy, M D , as Senior Vice President of Medical Affairs

Crinetics Pharmaceuticals Appoints Robert M Cuddihy, M D , as Senior Vice President of Medical Affairs
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

University of massachusettsUnited statesInternational centerUniversity of massachusetts medical schoolCorey davisScott struthersCapsida biotherapeuticsRobertm cuddihyNatalie badilloHarvard medical schoolExchange commissionSecurities exchangeCrinetics pharmaceuticals incInternational diabetes centerJanssen pharmaceutical companies of johnsonDartmouth hitchcock medical center

Crinetics Pharmaceuticals Appoints Robert M Cuddihy, M D , as Senior Vice President of Medical

Crinetics Pharmaceuticals Appoints Robert M Cuddihy, M D , as Senior Vice President of Medical
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

University of massachusettsUnited statesUniversity of massachusetts medical schoolInternational centerRobertm cuddihyCorey davisNatalie badilloScott struthersCapsida biotherapeuticsSecurities exchangeUniversity of minnesota medical schoolDartmouth hitchcock medical centerExchange commissionUniversity of massachusetts amherstInternational diabetes centerHead of corporate communications

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives $58 42 Consensus Price Target from Brokerages

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […]

Robertw bairdMarc wilsonDana pizzutiNews ratings for crinetics pharmaceuticals dailyArtal groupJanus henderson groupCrinetics pharmaceuticals incCantor fitzgeraldCrinetics pharmaceuticalsJennison associatesAnalyst recommendations for crinetics pharmaceuticalsPricet rowe associates incInstitutional investors weigh in on crinetics pharmaceuticalsMorgan stanleyCrinetics pharmaceuticals stock performanceSecurities exchange commission

Robert W Baird Boosts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $62 00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target boosted by Robert W. Baird from $52.00 to $62.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities research analysts have also recently commented on CRNX. Oppenheimer raised their […]

United statesStephenf betzPiper sandlerRichard scott struthersRobertw bairdNews ratings for crinetics pharmaceuticals dailyVictory capital management incAnalyst recommendations for crinetics pharmaceuticalsSecurities exchange commissionCrinetics pharmaceuticals stock performancePrincipal financial group incCrinetics pharmaceuticals incCrinetics pharmaceuticalsMirae asset global investments coFree reportModerate buy

Crinetics Pharmaceuticals (CRNX) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $60.00 price target on the stock. A number of other equities analysts also recently weighed in on the company. JMP Securities reiterated a market […]

Stephenf betzRobertw bairdPiper sandlerMarc wilsonAnalyst recommendations for crinetics pharmaceuticalsAlps advisors incCrinetics pharmaceuticals company profileNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticals price performanceHennion walsh asset management incComerica bankSecurities exchange commissionCrinetics pharmaceuticalsCantor fitzgeraldCrinetics pharmaceuticals incFree report